Stem cell transplantation for patients with Evans syndrome

Expert Review of Clinical Immunology

Volumn 5, Issue 3, 2009, Pages 341-348

  Benesch, Martin ^a   Urban, Christian ^a   Platzbecker, Uwe ^b   Passweg, Jakob ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Autologous hematopoietic stem cell transplantation; Evans syndrome

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; IMMUNOGLOBULIN; INTERFERON; INTERLEUKIN 2; MELPHALAN; MERCAPTOPURINE; METHYLPREDNISOLONE; PEGINTERFERON ALPHA2A; RITUXIMAB; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY; TIOGUANINE; VINCRISTINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; COMORBIDITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOINCOMPATIBILITY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; REVIEW;

EID: 77649085551     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.9     Document Type: Review

References (52)

1. Fisher JA. The cryptogenic acquired haemolytic anaemias. Quart. J. Med. 16, 245-262 (1947).
2. Evans RS, Takahashi K, Duane RT, Payne RT, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia. Arch. Intern. Med. 87(1), 48-65 (1951).
3. Pui C, Wilimas J, Wang W. Evans syndrome in childhood. J. Pediatr. 97(5), 754-758 (1980).
4. Sava?an S, Warrier I, Ravindranath Y. The spectrum of Evans' syndrome. Arch. Dis. Child. 77(3), 245-248 (1997).
5. Mathew P, Chen G, Wang W. Evans syndrome: results of a national survey. J. Pediatr. Hematol. Oncol. 19(5), 433-437 (1997).
6. Ng SC. Evans syndrome: a report on 12 patients. Clin. Lab. Haematol. 14(3), 189-193 (1992).
7. Norton A, Roberts I. Management of Evans syndrome. Br. J. Haematol. 132(2), 125-137 (2005).
8. Blouin P, Auvrignon A, Pagnier A et al. Evans syndrome: a retrospective study from the SHIP (French Society of Pediatric Hematology and Immunology [36 cases]). Arch. Pediatr. 12(11), 1600-1607 (2005).
9. Dash S, Marwaha R, Trehan A. Attenuated form of Evans syndrome among pediatric ITP patients. Indian Pediatr. 43(4), 340-343 (2006).
10. Yarali N, Demirceken F, Kondolat M, Ozkasap S, Kara A, Tunc B. A rare condition associated with celiac disease: Evans syndrome. J. Pediatr. Hematol. Oncol. 29(9), 633-635 (2007).
11. Michel M, Chanet V, Galicier L et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 83(4), 254-263 (2004).
12. Teachey DT, Manno CS, Axsom KM et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome. Blood 105(6), 2443-2448 (2005).
13. Ucci G, Ferrando P, Valentini D, Zavallone L. A case of Evans' syndrome in a patient with ulcerative colitis. Dig. Liver Dis. 35(6), 439-441 (2003).
14. Sultan SM, Begum S, Isenberg DA. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology 42(2), 230-234 (2003).
15. Font J, Jiménez S, Cervera R et al. Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases. Ann. Rheum. Dis. 59(11), 920-923 (2000).
16. Conti L, Iurlo A, Gandolfo GM, Girelli G. Evans' syndrome in paroxysmal nocturnal hemoglobinuria. Acta Haematol. 73(4), 210-211 (1985).
17. Alioglu B, Avci Z, Ozyurek E, Ozbek N. Visceral leishmaniasis presented with Evans syndrome: a case report. Am. J. Hematol. 82(11), 1030-1031 (2007).
18. Pavone P, Praticò AD, Castellano-Chiodo D, Ruggieri M. Pseudohypoparathyroidism Ia with Evans syndrome. J. Pediatr. Hematol. Oncol. 30(8), 628-630 (2008).
19. Ramos-Casals M, García-Carrasco M, López-Medrano F et al. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore) 82(2), 87-96 (2003).
20. DePiero AD, Lourie EM, Berman BW, Robin NH, Zinn AB, Hostoffer RW. Recurrent immune cytopenias in two patients with Di George/velocardiofacial syndrome. J. Pediatr. 131(3), 484-486 (1997).
21. Jasty R, Strouse PJ, Castle VP. Fatal lymphoproliferative disease as a complication of Evans syndrome. J. Pediatr. Hematol. Oncol. 22(5), 460-463 (2000).
22. Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol. 107(3), 133-144 (2002).
23. Lambotte O, Gelu-Simeon M, Maigne G et al. Pegylated interferon a-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. J. Infect. 51(3), e113-e115 (2005).
24. Abdel-Raheem MM, Potti A, Kobrinsky N. Severe Evans's syndrome secondary to interleukin-2 therapy: treatment with chimeric monoclonal anti-CD20 antibody. Ann. Hematol. 80(9), 543-545 (2001).
25. Shvidel L, Shtarlid M, Klepfish A, Sigler E, Berrebi A. Evans syndrome complicating fludarabine treatment for advanced B-CLL. Br. J. Haematol. 99(3), 706 (1997).
26. Au WY, Lo CM, Hawkins BR, Ma ES, Lie AK, Kwong YL. Evans' syndrome complicating chronic graft versus host disease after cadaveric liver transplantation. Transplantation 72(3), 527-528 (2001).
27. Page KM, Mendizabal AM, Prasad VK et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol. Blood Marrow Transplant. 14(10), 1108-1117 (2008).
28. Gonzalez-Vicent M, Diaz MA, Garcia- Sanchez F, Molina J, Madero L. Early onset of Evans syndrome following autologous peripheral blood progenitor cell transplantation in a child. Haematologica 87(5), ECR17 (2002).
29. Keung YK, Cobos E, Bolanos-Meade J, Issarachai S, Brideau A, Morgan D. Evans syndrome after autologous bone marrow transplant for recurrent Hodgkin's disease. Bone Marrow Transplant. 20(12), 1099-1101 (1997).
30. Winiarski J, Ringden O, Remberger M, Dalianis T, Ljungman P, Borgstrom B. Bone marrow transplantation in children using unrelated donors at Huddinge Hospital. Acta Paediatr. 85(3), 327-335 (1996).
31. Urban C, Benesch M, Sovinz P, Schwinger W, Lackner H. Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome. Eur. J. Haematol. 72(6), 444-447 (2004).
32. Sobota A, Neufeld EJ, Lapsia S, Bennett CM. Response to mercaptopurine for refractory autoimmune cytopenias in children. Pediatr. Blood Cancer 52(1), 80-84 (2009).
33. Kotb R, Pinganaud C, Trichet C et al. Efficacy of mycophenolate mofetil in adult refractory autoimmune cytopenias: a single center preliminary study. Eur. J. Haematol. 75(1), 60-64 (2005).
34. Scaradavou A, Bussel J. Evans syndrome: results of a pilot study utilizing a multiagent treatment protocol. J. Pediatr. Hematol. Oncol. 17(4), 290-295 (1995).
35. Zecca M, Nobili B, Ramenghi U et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia. Blood 101(10), 3857-3861 (2003).
36. Bader-Meunier B, Aladjidi N, Bellmann F et al. Rituximab therapy for childhood Evans syndrome. Haematologica 92(12), 1691-1694 (2007).
37. Shanafelt TD, Madueme HL, Wolf RC, Tefferi A. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin. Proc. 78(11), 1340-1346 (2003).
38. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435(7042), 620-627 (2005).
39. Hinterberger W, Hinterberger-Fischer M, Marmont A. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant. 30(11), 753-759 (2002).
40. Brodsky RA, Petri M, Smith BD et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann. Intern. Med. 129(12), 1031-1035 (1998).
41. Huhn RD, Fogarty PF, Nakamura R et al. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 101(1), 71-77 (2003).
42. Musso M, Porretto F, Crescimanno A et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 7(7), 492-494 (1998).
43. Urban C, Lackner H, Sovinz P et al. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation. Eur. J. Haematol. 76(6), 526-530 (2006).
44. Passweg JR, Rabusin M, Musso M et al. Haematopoietic stem cell transplantation for refractory autoimmune cytopenia. Br. J. Haematol. 125(6), 749-755 (2004).
45. Passweg JR, Rabusin M. Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias. Autoimmunity 41(8), 41, 660-665 (2008).
46. Martino R, Sureda A, Brunet S. Peripheral blood stem cell mobilization in refractory autoimmune Evans syndrome: a cautionary case report. Bone Marrow Transplant. 20(6), 521 (1997).
47. Daikeler T, Hügle T, Farge D et al. Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant. (2009) (Epub ahead of print).
48. Oyama Y, Papadopoulos EB, Miranda M, Traynor AE, Burt RK. Allogeneic stem cell transplantation for Evans syndrome. Bone Marrow Transplant. 28(9), 903-905 (2001).
49. Marmont AM, Gualandi F, Occhini D et al. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. Autoimmunity 39(6), 505-511 (2006).
50. Raetz E, Beatty PG, Adams RH. Treatment of severe Evans syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant. 20(5), 427-429 (1997).
51. Caselli D, Farruggia P, Trizzino A et al. Split chimerism may be enough to cure Evans syndrome. Bone Marrow Transplant. 38(4), 311 (2006).
52. Marmont AM, Gualandi F, van Lint MT, Bacigalupo A. Refractory Evans syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versusautoimmunity effect. Bone Marrow Transplant. 31(5), 399-402 (2003).